SM03
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SM03, covering 2019-12-10 to 2021-01-08. Get the full timeline:
Most recent: Clinical Trial Update: A Study Assessing the Efficacy and Safety of SM03 in Patients With Active Rheumatoid Arthritis Receiving MTX [Phase 3]